TITLE

Adeona receives additional funding for multiple sclerosis trial

PUB. DATE
February 2010
SOURCE
PharmaWatch: CNS;Feb2010, Vol. 9 Issue 2, p4
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
The article reports that the clinical trial for Adeona Pharmaceuticals Inc.'s multiple sclerosis (MS) drug, Trimesta, received 860,440 dollars in grant funding from the American Recovery and Reinvestment Act in the U.S. It notes that the clinical trial had received five million dollars grant from the National Multiple Sclerosis Society. It mentions that clinical investigators will give Trimesta and glatimer acetate (Copaxone) to women between the age of 18 and 50 with relapsing-remitting MS.
ACCESSION #
47908497

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics